a:3:{s:6:"_token";s:40:"ymtuY8Sb38UpNlXc1nKK42EQGlXnrY5ilyOq5ckX";s:9:"_previous";a:1:{s:3:"url";s:207:"https://www.pharmafocusasia.com/news/carsgens-ct011-secures-nmpa-investigational-new-drug-clearance-for-stage-a-hepatocellular-carcinoma-with-high-recurrence-risk-after-surgical-resection-and-gpc3-positivity";}s:6:"_flash";a:2:{s:3:"old";a:0:{}s:3:"new";a:0:{}}}